COMPANY PROFILE

Sware

Explore full profile

AI-powered Intelligent GxP validation software and services for regulated life sciences companies

Boston, United StatesFounded 2010Other B2B Software

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Sware

Sware is a software and services company providing GxP validation solutions for the life sciences industry. Its platform, Res_Q, helps regulated companies plan, document, track, and validate computer systems in compliance with GxP regulations, supporting computer system validation (CSV,, computer software assurance (CSA,, and the validation of AI-based systems. The platform offers pre-built templates, SOPs, test scripts, and workflows, along with automated risk assessments, audit trails, and real-time visibility into validation workloads across the organization. Customers include quality, IT, and digital transformation teams at pharmaceutical, biotech, and other life sciences companies. Sware also provides professional services and validation expertise, and integrates with enterprise systems such as Salesforce Life Sciences Cloud and Box. Founded in 2010 in Boston, the company rebranded from Boston Technology Research to Sware in 2022.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2010
Headquarters: Boston, United States
Employees: 69
Open positions: 1
Dealroom signal: 69.8/100
Industry: Legal, Enterprise Software
Sub-industry: RegTech & Compliance
Sector: Other B2B Software, Risk Management, Compliance, Biotechnology, Consulting Services, Regtech Compliance
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Jun 2024	$6M	$75M	Insight Partners · LRVHealth · New Stack Ventures · First Analysis	↗
DEBT✓Debt	Nov 2023	$1.5M	—	Undisclosed	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Sware website traffic

Latest recorded traffic for Sware is 9.2K monthly website visits, up 95.7% over the last three months. Sware's team grew 1.5% over the past year.

Latest monthly visits9.2K 3-month web change+95.7% 1-year team growth+1.5%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Vice President of ProductBoston, United States · Business Development · Jul 29, 2026

1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ICInstitutional Biosafety CorpPioneer in efficient research compliance and cutting-edge biosafety	Rockville, United States	Acquired	1,391	—	—
NSNCircle Network SecurityAgentless security risk and compliance management solutions for its clients	San Francisco, United States	Acquired
TGThe Avoca GroupTech-enabled services focused on improving quality and compliance in clinical trial execution	Princeton, United States	Acquired
POPolarisPolaris delivers innovative, best-in-class solutions for today’s toughest life science challenges	New York City, United States	Operational
REREGISTRAT-MAPIClinical research organization focusing on late phase studies for biopharmaceutical and medical device companies	Lexington, United States	Operational
3C3R Pharma ConsultingRegulatory Affairs - 3R Pharma Consulting - reducing regulatory risk	Dobel, Germany	Operational
ELElixinPharmaElixinPharma was founded in 1999 to assist new and emerging pharmaceutical companies with their Chemistry, Manufacturing	Encinitas, United States	Operational
OSOrchid Orthopedic SolutionsOrchid Orthopedic Solutions offers medical device outsourcing services from design and development through finished goods manufacturing	Mason, United States	Acquired